Powered by the Evidence-based Practice Centers
Evidence Reports All of EHC
Evidence Reports All of EHC

SHARE:

FacebookTwitterFacebookPrintShare

morgellons disease, when will there be a treament availbe for people to use to combat this disease?

Briefly describe a specific question, or set of related questions, about a health care test or treatment that this program should consider.

morgellons disease, when will there be a treament availbe for people to use to combat this disease?

Does your question include a comparison of different health care approaches? (If no, your topic will still be considered.)

no

If yes, explain the specific technologies, devices, drugs, or interventions you would like to see compared:
What patients or group(s) of patients does your question apply to? (Please include specific details such as age range, gender, coexisting diagnoses, and indications for therapy.)

myself 61 yrs old female-does have this disease

Are there subgroups of patients that your question might apply to? (For example, an ethnic group, stage or severity of a disease.)

brain fog. sleeping all the time

Describe the health-related benefits you are interested in. (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

stop it rom itching an biting

Describe any health-related risks, side effects, or harms that you are concerned about.

Appropriateness for EHC Program

Does your question include a health care drug, intervention, device, or technology available (or likely to be available) in the U.S.?

yes

Which priority area(s) and population(s) does this topic apply to? (check all that apply)
EHC Priority Conditions (updated in 2008)
AHRQ Priority Populations
  • Elderly
Federal Health Care Program
  • Medicaid
  • Medicare

Importance

Describe why this topic is important.

i have had this problem for 56 =yrs an have been told bye alot dermotorogy doctors it doesnt exsit but it does.

What specifically motivated you to ask this question? (For example, you are developing a clinical guideline, working with a policy with large uncertainty about the appropriate approach, costly intervention, new research you have read, items in the media you may have seen, a clinical practice dilemma you know of, etc.)

know other people ahve it

Does your question represent uncertainty for clinicians and/or policy-makers? (For example, variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision.)

no

If yes, please explain:

Potential Impact

How will an answer to your research question be used or help inform decisions for you or your group?

it will put a stop to the bugs

Describe the timeframe in which an answer to your question is needed.

now

Describe any health disparities, inequities, or impact on vulnerable populations your question applies to.

Nominator Information

Other Information About You: (optional)
Please choose a description that best describes your role or perspective: (you may select more than one category if appropriate)

it will put a stop to the bugs

Are you making a suggestion as an individual or on behalf of an organization?

Individual

Please tell us how you heard about the Effective Health Care Program
Page last reviewed November 2017
Page originally created August 2009

Internet Citation: morgellons disease, when will there be a treament availbe for people to use to combat this disease?. Content last reviewed November 2017. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
https://effectivehealthcare.ahrq.gov/get-involved/nominated-topics/morgellons-disease-when-will-there-be-a-treament-availbe-for-people-to-use-to-combat-this-disease

Select to copy citation